ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 199 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $231,479 | -10.4% | 5,724 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $258,419 | -6.7% | 5,555 | +3.9% | 0.00% | -33.3% |
| Q3 2022 | $277,000 | +10.8% | 5,347 | +1.2% | 0.00% | +50.0% |
| Q2 2022 | $250,000 | -29.0% | 5,285 | +6.9% | 0.00% | -33.3% |
| Q1 2022 | $352,000 | -3.8% | 4,945 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $366,000 | +30.2% | 4,897 | -1.1% | 0.00% | +50.0% |
| Q3 2021 | $281,000 | +29.5% | 4,951 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $217,000 | -11.4% | 4,935 | -0.7% | 0.00% | 0.0% |
| Q1 2021 | $245,000 | +17.8% | 4,968 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $208,000 | -11.5% | 4,937 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $235,000 | -64.3% | 5,131 | -51.8% | 0.00% | -75.0% |
| Q4 2019 | $658,000 | -41.5% | 10,655 | -43.1% | 0.01% | -42.9% |
| Q3 2019 | $1,125,000 | -46.0% | 18,724 | -24.2% | 0.01% | -41.7% |
| Q2 2019 | $2,085,000 | -10.1% | 24,715 | +1.7% | 0.02% | -14.3% |
| Q1 2019 | $2,320,000 | +35.2% | 24,293 | +0.3% | 0.03% | +27.3% |
| Q4 2018 | $1,716,000 | -11.8% | 24,229 | +6.4% | 0.02% | +22.2% |
| Q3 2018 | $1,946,000 | -20.3% | 22,769 | +8.0% | 0.02% | -28.0% |
| Q2 2018 | $2,443,000 | +33.1% | 21,082 | -7.1% | 0.02% | +31.6% |
| Q1 2018 | $1,836,000 | +30.4% | 22,697 | -5.4% | 0.02% | +35.7% |
| Q4 2017 | $1,408,000 | +306.9% | 23,997 | +224.3% | 0.01% | +250.0% |
| Q3 2017 | $346,000 | +33.6% | 7,400 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $259,000 | +16.7% | 7,200 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $222,000 | -7.9% | 7,200 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $241,000 | +14.2% | 7,200 | +12.5% | 0.00% | +33.3% |
| Q4 2015 | $211,000 | -7.5% | 6,400 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $228,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |